1. On September 13, 2010, the company was established, the Xi 'an High-tech Base was put into use, and the medical device production license was obtained.
2. The national innovative medical device "MTHFR C677T Gene Detection Kit (PCR-Gold Magnetic Particle Chromatography Method)" has been approved for the registration certificate of Class III in vitro diagnostic reagents.
3. The domestic first "Magnetic Quantitative Immunoassay Analyzer and its Supporting series of Test Kits" has been approved for marketing.
4. The domestic alternative "Thromboelastography Series Test Kits" have been approved for seven registration certificates.
5. Has presided over and completed four national-level projects, including the National Major Science and Technology Special Project, the National Major Science and Technology Achievement Transformation Project, and the National Torch Program.
6. Selected for high-level talent programs such as "Key Scientific and Technological Innovation Teams of Shaanxi Province" and "Young Science and Technology New Stars of Shaanxi Province".
7. It was approved to establish innovative research and development platforms such as the "Shaanxi Province Nano-Biomedical Engineering Research Center" and the "Shaanxi Province Academician and Expert Workstation".
8. It was recognized as a unicorn cultivation enterprise in Xi 'an High-tech Zone and won the silver award in the National Science and Technology Workers' Innovation and Entrepreneurship Competition organized by the China Association for Science and Technology.
1.The second category of innovative medical devices, "Lipid New Standard - Oxidized Low-density Lipoprotein (OxLDL) Series Detection Kit", has been approved for marketing (POCT, ELISA, immunoturbidimetry).
2. Has presided over 4 provincial and ministerial-level projects, including key projects of the National Key Research and Development Program, "Challenge and Response" projects of the Shaanxi Provincial Key Research and Development Program, and the Shaanxi Provincial Science and Technology Enterprises' "STAR Market" listing cultivation Project.
3. It has been approved as the "Four Subjects and One Joint" university-Enterprise Joint Research Center of Shaanxi Province, the Postdoctoral Innovation Base of Shaanxi Province and Xi 'an City, the Xi 'an Engineering Research Center for Clinical In Vitro Diagnostic Reagents and other new research and development institutions.
4. It was commended by the Ministry of Science and Technology as an "Advanced Collective in the National Science and Technology System's Fight Against COVID-19", won the Silver Award of the Invention and Innovation Award from the China Association for Invention, was recognized as a "Specialized, Refined, Unique and Innovative" Small and medium-sized enterprise in Shaanxi Province, and was named a star of hard technology enterprises in Xi 'an.
5. The R&D team has been selected for high-level talent programs such as "Shaanxi Province's Leading Talents in Science and Technology Innovation for Middle-aged and Young People" and "National Leading Talents of Xi 'an City".
